天域生物(603717.SH)终止2025年度向特定对象发行A股股票事项并撤回申请文件

Core Viewpoint - Tianyu Biotech (603717.SH) has decided to terminate its plan for a specific issuance of A-shares for the year 2025 and will withdraw the related application documents [1] Group 1 - The fifth board meeting of the company will be held on February 11, 2026, to review the decision [1] - The company will apply to the Shanghai Stock Exchange to withdraw the relevant documents regarding the A-share issuance [1]